Seattle based company Geospiza has been around the block a time or two in the bioinformatics business, and after 14 years in the game, it has come to the end of the road.
The bioinformatics company, which makes software for scientists who analyze data from genetic experiments, said last week it has agreed to be acquired by Waltham-based PerkinElmer, the giant maker of tools for life scientists.
"Genomic information is becoming increasingly important in understanding and treating disease,'' said Richard Begley, PerkinElmer's president of emerging technologies and bioinformatics, in a statement.
Geospiza has been one of the small and persistent voices in the market that has insisted biologists need better software to manage genomic information and PerkinElmer provides just this especially for bioinformatics. The company struggled to get traction with this argument in the wake of the Human Genome Project of bioinformatics, but was able to weather the storm as competitors fell by the wayside, and the market eventually became more attractive